Outlook on the Global Cardiovascular Monitoring and Diagnostic Devices & Equipment Market (2018 to 2022) - Key Players Include Medtronic, Boston Scientific & GE Healthcare Among Others - ResearchAndMarkets.com
The North American Market is the largest market for cardiovascular monitoring and diagnostic devices and equipment and is expected to continue to be the largest market during the forecast period.
The "Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.
The global cardiovascular monitoring and diagnostic devices and equipment market was valued at about $3.1 billion in 2018 and is expected to grow to $3.46 billion at a CAGR of 2.8% through 2022.
The cardiovascular monitoring and diagnostic devices and equipment market has been geographically segmented into North America, Western Europe, Asia-Pacific, Eastern Europe, South America and Middle East & Africa. The North American Market is the largest market for cardiovascular monitoring and diagnostic devices and equipment and is expected to continue to be the largest market during the forecast period.
The cardiovascular monitoring and diagnostic devices and equipment market is being driven by an increasing number of people suffering from obesity and diabetes. Risk factors including high blood pressure and high cholesterol are associated with obesity and diabetes leads to cardiovascular diseases. For instance, as per a study conducted by the American Heart Association (AMA) in 2015, more than 68 percent of people who are aged 65 or older and have diabetes end up with cardiovascular related deaths. According to another study conducted by AMA in 2015, people who have diabetes are two to four times more likely to suffer deaths related to cardiovascular diseases.
Companies in the cardiovascular monitoring and diagnostic devices and equipment market are developing implantable cardiac monitors (ICM) to monitor the heart rhythm. ICMs continuously monitor the electrocardiogram (ECG) of the patient to conduct a real-time examination of the heart rhythm, for up to 36 months. ICMs are mostly used in the analysis of transitory symptoms which have an arrhythmic origin, such as unexplained palpitations. For example, in 2017 Medtronic developed an ICM, the smallest implantable monitor in the market, which makes use of wireless connectivity to download the patient's data and sends this data to physicians over the internet.
The US FDA has classified cardiovascular monitoring and diagnostic devices into the class II category, as they have a moderate to high risk associated with usage. Class II devices are bounded by device specific regulations which include performance standards, premarket data requirements, postmarket surveillance and labelling requirements associated with device usage. For instance, the labelling should consist of contraindications, adverse reactions, precautions, warnings and other instructions before the device is released into the market.
Major players in the market are Medtronic PLC, Boston Scientific Corporation, GE Healthcare, Johnson & Johnson and Philips Healthcare.
Key Topics Covered:
1. Executive Summary
2. Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Characteristics
3. Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Size And Growth
3.1. Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market
4. Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Segmentation
4.1. Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Cardiopulmonary Stress Testing Systems
- ECG Data Management Systems
- ECG Monitoring Equipment
- ECG Stress Testing Systems
- Event Monitoring Systems
- Holter Monitoring Systems
4.2. Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market, Segmentation By End-Use, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
- Hospitals/Physician Clinic (Continuous Glucose Monitors)
- Home/Emergency
- Research and Development (Clinical Trials, Universities, CRO)
5. Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Regional And Country Analysis
5.1. Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
Companies Mentioned
- Medtronic PLC
- Boston Scientific Corporation
- GE Healthcare
- Johnson & Johnson
- Philips Healthcare
- Siemens Healthcare
- St. Jude MedicalInc
- Nihon Kohden Corporation
- FUKUDA DENSHI Co. Ltd.
- Sorin Group
-
Welch Allyn Inc.
For more information about this report visit https://www.researchandmarkets.com/r/c4rpgw
View source version on businesswire.com: https://www.businesswire.com/news/home/20200318005335/en/